Postoperative Irradiation for Stage T4 Colon Cancer

John Han-Chih Chang, MD
OncoLink Assistant Editor
Ultima Vez Modificado: 2 de noviembre del 1999

Share article


English

Presenter: Christopher Willett, MD
Affiliation: Massachusetts General Hospital, Boston, MA and Roswell Park Cancer Institute, Buffalo, NY

Background:
Postoperative systemic therapy is the standard of care for intermediate to advanced colon cancer. Radiation therapy (RT) has been utilized far less due to the technical considerations such as not being able to localize the target. In T4 disease, by definition, there has been invasion into adjacent structures, which are usually more "fixed" in location and more easily targeted. Hence, the authors investigated their long term experience with this patient population receiving postoperative RT.

Materials and Methods:

  • One hundred and fifty-two patients having undergone a resection of a colon cancer were irradiated to 50 Gy to the tumor bed with or without 5-Flurouracil chemotherapy.
  • A majority of the patients had no evidence of either gross or microscopic residual disease.
Results:
  • Seventy-nine patients who had N0 or one lymph node positive disease had 10 year local control of 88%. Relapse free survival was 58% at 10 years.
  • Even patients who had T4 tumors complicated by perforations or fistulas had a nearly similar local control and relapse free survival rate.
  • Those with gross residual disease were not well controlled, and relapse free survival was 19% at 10 years.
Clinical/Scientific Implications:
  1. In selected stage T4 colon cancers, postoperative RT may improve local control and relapse free survival.
  2. As with any retrospective review, patient selection biases may be a factor. However, the data presented in this series are compelling.
  3. Prospective trials should be pursued in the locally advanced colon cancer patients with established guidelines regarding systemic therapy, which has demonstrated its positive impact on this disease entity.

ASTRO coverage is sponsored, in part, by Varian Medical Systems, Inc.

English
News
ASTRO: Short Course of Breast Cancer Irradiation Effective

Sep 2, 2014 - A three week course of radiation treatment may be as effective as six weeks or more in patients with early-stage breast cancer, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago. In a related study presented at the meeting, adding radiation to the internal mammary lymph nodes does not improve survival in patients with early-stage breast cancer.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información